Mark R. Dowling — University of Queensland

Area of research

Oncology · Immunology

Research interest

Research interests include Muscarinic acetylcholine receptor, Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M1, and Medicine.

Recent publications

Long-lived IgE plasma cells persist in secondary lymphoid tissues using a navitoclax-sensitive survival program

Immunity 2025cited by 8position: middledoi

Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter's Transformation: An International Multicenter Retrospective Study

Blood 2023cited by 9position: middledoi

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease

Current Opinion in Pharmacology 2014cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Oncology · Immunology →